Cargando…

Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts

Background: Hepatic myofibroblasts (MFs) can originate from hepatic stellate cells, portal fibroblasts, or bone marrow-derived mesenchymal stem cells and can migrate towards the site of injury by aligning with nascent and established fibrotic septa in response to several mediators. Oncostatin M (OSM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foglia, Beatrice, Sutti, Salvatore, Pedicini, Dario, Cannito, Stefania, Bocca, Claudia, Maggiora, Marina, Bevacqua, Maria Rosaria, Rosso, Chiara, Bugianesi, Elisabetta, Albano, Emanuele, Novo, Erica, Parola, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017087/ https://www.ncbi.nlm.nih.gov/pubmed/31861914 http://dx.doi.org/10.3390/cells9010028

Ejemplares similares

Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
por: Di Maira, Giovanni, et al.
Publicado: (2022)

Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis
por: Bocca, Claudia, et al.
Publicado: (2022)

ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis
por: Foglia, Beatrice, et al.
Publicado: (2019)

Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation
por: Foglia, Beatrice, et al.
Publicado: (2021)

Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis
por: Foglia, Beatrice, et al.
Publicado: (2021)

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis
por: Cannito, Stefania, et al.
Publicado: (2017)

SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
por: Novo, Erica, et al.
Publicado: (2022)

Inflammatory processes involved in NASH-related hepatocellular carcinoma
por: Cannito, Stefania, et al.
Publicado: (2023)

SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells
por: Novo, Erica, et al.
Publicado: (2017)

Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
por: Foglia, Beatrice, et al.
Publicado: (2023)

Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer
por: Caligiuri, Alessandra, et al.
Publicado: (2022)

SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors-1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets
por: Cannito, Stefania, et al.
Publicado: (2019)

Angiogenesis and Fibrogenesis in Chronic Liver Diseases
por: Bocca, Claudia, et al.
Publicado: (2015)

Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC
por: Mattu, Sandra, et al.
Publicado: (2021)

Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
por: Locatelli, Irene, et al.
Publicado: (2014)

Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment
por: Foglia, Beatrice, et al.
Publicado: (2023)

Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression
por: Simonneau, Marie, et al.
Publicado: (2018)

MicroRNA Function in the Profibrogenic Interplay upon Chronic Liver Disease
por: Huang, Jia, et al.
Publicado: (2014)

Adaptive immunity: an emerging player in the progression of NAFLD
por: Sutti, Salvatore, et al.
Publicado: (2019)

Multimechanistic Antifibrotic Effect of Biochanin A in Rats: Implications of Proinflammatory and Profibrogenic Mediators
por: Breikaa, Randa M., et al.
Publicado: (2013)

Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
por: Hegde, Pushpa, et al.
Publicado: (2018)

Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators
por: Pastore, Mirella, et al.
Publicado: (2022)

Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis
por: Galastri, Sara, et al.
Publicado: (2012)

Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis
por: Han, Liang, et al.
Publicado: (2023)

Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo
por: Khodayari, Nazli, et al.
Publicado: (2020)

Synergy of Phospholipid—Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells
por: Valentino, Gina, et al.
Publicado: (2019)

Extracellular Matrix and Fibrocyte Accumulation in BALB/c Mouse Lung upon Transient Overexpression of Oncostatin M
por: Botelho, Fernando M., et al.
Publicado: (2019)

Oncostatin M Modulation of Lipid Storage
por: Elks, Carrie M., et al.
Publicado: (2015)

Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis
por: Zhang, Wei, et al.
Publicado: (2023)

CYP2E1 autoantibodies in liver diseases
por: Sutti, Salvatore, et al.
Publicado: (2014)

Gremlin mediates the TGF-β-induced induction of profibrogenic genes in human retinal pigment epithelial cells
por: Qin, Dong, et al.
Publicado: (2020)

A Novel Way of Preventing Postoperative Pancreatic Fistula by Directly Injecting Profibrogenic Materials into the Pancreatic Parenchyma
por: Lee, Sang Chul, et al.
Publicado: (2020)

ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis
por: Nalkurthi, Christina, et al.
Publicado: (2021)

The Enigmatic Cytokine Oncostatin M and Roles in Disease
por: Richards, Carl D.
Publicado: (2013)

Oncostatin M promotes lipolysis in white adipocytes
por: van Krieken, Pim P., et al.
Publicado: (2022)

Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial–mesenchymal transition and poor overall survival
por: Kucia-Tran, Justyna A, et al.
Publicado: (2016)

Prokaryotic soluble overexpression and purification of oncostatin M using a fusion approach and genetically engineered E. coli strains
por: Nguyen, Minh Tan, et al.
Publicado: (2019)

Redox mechanisms in hepatic chronic wound healing and fibrogenesis
por: Novo, Erica, et al.
Publicado: (2008)

The role of redox mechanisms in hepatic chronic wound healing and fibrogenesis
por: Novo, Erica, et al.
Publicado: (2012)

MMP‐13 deletion decreases profibrogenic molecules and attenuates N‐nitrosodimethylamine‐induced liver injury and fibrosis in mice
por: George, Joseph, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ishkmcbr0famd70ncokbelv9n2